Across the economy, hiring in recent months has ground to its slowest pace since the start of the pandemic, with employers ...

In a further jolt to the process of reviewing and recommending vaccines at the US Centers for Disease Control and Prevention, ...

U.S. President Donald Trump's administration is blocking funding for a swath of public-health programs run by the Centers for ...

Royal Caribbean had generated average returns on invested capital of more than 9% over the three years ended 2019; however, we believe the firm will handily surpass this level over the next five years ...

West Virginia will receive an estimated $980 million over the next 17 years from a global settlement of a class action ...

The US Centers for Disease Control and Prevention told physician groups, public health professionals and infectious disease experts that they will no longer be invited to help review vaccine data and ...

The U.S. Centers for Disease Control and Prevention told physician groups, public health professionals and infectious disease ...

Strong performance and sales acceleration with total net sales of CHF 58 million in H1 2025 and increase of 145% compared to ...

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. Ozempic and Rybelsus helped Novo gain share over Eli Lilly's once-weekly ...

Merck did not immediately respond to a request for comment on the job cuts. The company expects the program to cost about $3 billion to implement but would lead to $3 billion in annual cost savings by ...